Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Mao

Showing results (471-480 of 565) with videos related to

Pageof 57
Sort By:
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|July 31, 2013
[Surveillance of schistosome antibodies in population in mountainous schistosomiasis endemic regions in China]Zi-Song Wu, Meng Tang, Han-Gang Li, et al.
Cancer|October 24, 2018
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinomaRui Guo, Ling-Long Tang, Yan-Ping Mao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 2024
Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort studyWei-Wei Zhang, Jia-Yi Lin, Gao-Yuan Wang, et al.
Cancer Science|December 22, 2017
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapyJia-Wei Lv, Zhen-Yu Qi, Guan-Qun Zhou, et al.
Cancer|April 12, 2013
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of ChinaYong Chen, Ying Sun, Shao-Bo Liang, et al.
Chinese Journal of Cancer|December 21, 2017
Significant value of <sup>18</sup>F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapyHao Peng, Lei Chen, Ling-Long Tang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 12, 2007
[Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system]Yan-Ping Mao, Ming-Huang Hong, Ying Sun, et al.
BMC Cancer|October 17, 2015
Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysisFan Zhang, Yi-Kan Cheng, Wen-Fei Li, et al.
Cancer Medicine|March 31, 2022
The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinomaXiao-Min Li, Xiao-Min Zhang, Jun-Yan Li, et al.
Oral Oncology|March 9, 2019
Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrualYa-Qin Wang, Jia-Wei Lv, Ling-Long Tang, et al.
Pageof 57

Showing results (471-480 of 565) with videos related to

Sort By:
Pageof 57
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|July 31, 2013
[Surveillance of schistosome antibodies in population in mountainous schistosomiasis endemic regions in China]Zi-Song Wu, Meng Tang, Han-Gang Li, et al.
Cancer|October 24, 2018
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinomaRui Guo, Ling-Long Tang, Yan-Ping Mao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 2024
Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort studyWei-Wei Zhang, Jia-Yi Lin, Gao-Yuan Wang, et al.
Cancer Science|December 22, 2017
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapyJia-Wei Lv, Zhen-Yu Qi, Guan-Qun Zhou, et al.
Cancer|April 12, 2013
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of ChinaYong Chen, Ying Sun, Shao-Bo Liang, et al.
Chinese Journal of Cancer|December 21, 2017
Significant value of <sup>18</sup>F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapyHao Peng, Lei Chen, Ling-Long Tang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 12, 2007
[Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system]Yan-Ping Mao, Ming-Huang Hong, Ying Sun, et al.
BMC Cancer|October 17, 2015
Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysisFan Zhang, Yi-Kan Cheng, Wen-Fei Li, et al.
Cancer Medicine|March 31, 2022
The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinomaXiao-Min Li, Xiao-Min Zhang, Jun-Yan Li, et al.
Oral Oncology|March 9, 2019
Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrualYa-Qin Wang, Jia-Wei Lv, Ling-Long Tang, et al.
Pageof 57